GSTM1 and diabetes mellitus: Four patients were on diabetes diet only, while 16 had a metformin monotherapy (Hb) or were on a combination with other oral glucose lowering drugs (4 on DPP4-inhibitors and 7 on SGLT2-inhibitors).